Eugene Melnyk to set up Trimel in Biovail battle
This article was originally published in Scrip
Executive Summary
Eugene Melnyk, the former chairman and CEO ofBiovail, has abandoned his plans to install a new board of directors at the company and now plans to set up his own drug firm, Trimel Pharmaceuticals.